Literature DB >> 3799241

Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids.

R Andersson, B E Malmvall, B A Bengtsson.   

Abstract

Ninety patients with giant cell arteritis (GCA) were followed for 9-16 years after diagnosis. Corticosteroids were given to all but one patient. Forty-two patients died during the observation period (27 women and 15 men). The survival was compared with that in the general population and found not to be reduced among the GCA patients. In fact, we found a lower mortality than expected after five years from diagnosis (p less than 0.05). We did not see any increase in deaths due to vascular or malignant diseases in our patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3799241     DOI: 10.1111/j.0954-6820.1986.tb02778.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy.

Authors:  E Nordborg; B A Bengtsson
Journal:  BMJ       Date:  1989-08-26

Review 2.  Giant cell arteritis: difficult decisions in diagnosis, investigation and treatment.

Authors:  E W Paice
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

3.  Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.

Authors:  Tanaz A Kermani; Kenneth J Warrington; Cynthia S Crowson; Steven R Ytterberg; Gene G Hunder; Sherine E Gabriel; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

4.  Giant cell arteritis and mortality.

Authors:  R Wade Crow; Bradley J Katz; Judith E A Warner; Stephen C Alder; Kang Zhang; Susan Schulman; Kathleen B Digre
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-04       Impact factor: 6.053

5.  Risk of vascular events in patients with polymyalgia rheumatica.

Authors:  Adam T Hancock; Christian D Mallen; Sara Muller; John Belcher; Edward Roddy; Toby Helliwell; Samantha L Hider
Journal:  CMAJ       Date:  2014-07-28       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.